You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory Metastic Sarcoma

Showing 1 - 25 of 10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma Trial (Lurbinectedin)

Not yet recruiting
  • Refractory Ewing Sarcoma
  • +2 more
  • (no location specified)
Feb 15, 2023

Ewing Sarcoma Trial in Warsaw (Naxitamab)

Not yet recruiting
  • Ewing Sarcoma
  • Warsaw, Mazowian, Poland
    Mother and Child Institute
Jul 28, 2023

Ewing Sarcoma, Osteosarcoma Trial in San Francisco, Aurora, Philadelphia (Cabozantinib)

Recruiting
  • Ewing Sarcoma
  • Osteosarcoma
  • San Francisco, California
  • +4 more
Nov 24, 2023

Refractory HIV Associated Kaposi Sarcoma Trial (Dostarlimab in Combination Antiretroviral Therapy)

Not yet recruiting
  • Refractory HIV Associated Kaposi Sarcoma
  • Dostarlimab in Combination Antiretroviral Therapy
  • (no location specified)
Dec 2, 2022

Kaposi Sarcoma, Classic Kaposi Sarcoma, Refractory Kaposi Sarcoma Trial (Pembrolizumab + Lenvatinib)

Not yet recruiting
  • Kaposi Sarcoma
  • +2 more
  • Pembrolizumab + Lenvatinib
  • (no location specified)
Apr 27, 2023

Sarcoma Trial in Guangzhou (chidamide and toripalimab)

Recruiting
  • Sarcoma
  • chidamide and toripalimab
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Univerisity
Sep 4, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • +2 more
  • CPI 613
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
May 10, 2023

Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)

Recruiting
  • Pediatric Sarcoma, Refractory
  • Pediatric Sarcoma, Relapsed
  • GEM/DOX + TGFBi expanded NK cells
  • Tampa, Florida
  • +1 more
Jan 3, 2023

Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

Recruiting
  • Metastatic Leiomyosarcoma
  • +17 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 13, 2022

Sarcoma, Ewing Trial in China (TK216+Vincristin)

Not yet recruiting
  • Sarcoma, Ewing
  • TK216+Vincristin
  • Beijing, Beijing, China
  • +7 more
Jul 25, 2022

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)

Active, not recruiting
Has Results
  • Refractory Soft Tissue Sarcomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 5, 2022

Osteosarcoma, Sarcoma Trial (HS-20093)

Not yet recruiting
  • Osteosarcoma
  • Sarcoma
  • (no location specified)
Apr 26, 2023

Sarcoma, Clear Cell Trial in United States (CPI-613 + Hydroxychloroquine)

Recruiting
  • Sarcoma, Clear Cell
  • CPI-613 + Hydroxychloroquine
  • Duarte, California
  • +7 more
Nov 10, 2022

Sarcoma Trial in Seoul (Pemetrexed, cisplatin)

Active, not recruiting
  • Sarcoma
  • Pemetrexed, cisplatin
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
May 30, 2022

Ewing Sarcoma, Ewing-Like Sarcoma Trial in New York (LY2880070, Gemcitabine)

Recruiting
  • Ewing Sarcoma
  • Ewing-Like Sarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 18, 2022

Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))

Recruiting
  • Osteosarcoma
  • +3 more
  • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
  • Xi'an, Shaanxi, China
    Xi'an Honghui Hospital
May 8, 2023

Sarcoma Trial in Shanghai (Apatinib monotherapy)

Recruiting
  • Sarcoma
  • Apatinib monotherapy
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiao Tong University School of Medicine
May 18, 2022

Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)

Not yet recruiting
  • Sarcoma, Ewing
  • Rhabdomyosarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Osteosarcoma, Ewing Sarcoma of Bone Trial in Warsaw (Regorafenib)

Recruiting
  • Osteosarcoma
  • Ewing Sarcoma of Bone
  • Warsaw, Mazovian, Poland
    Mother and Child Institute
Sep 7, 2022

Tumor, Desmoplastic Small Round Cell, Adult, Tumor, Desmoplastic Small Round Cell, Childhood, Sarcoma, Ewing Trial in Spain (nab

Completed
  • Tumor, Desmoplastic Small Round Cell, Adult
  • +4 more
  • nab paclitaxel
  • Barcelona, Spain
  • +6 more
Jun 6, 2022

Sarcoma,Soft Tissue Trial in Guangzhou (anlotinib and toripalimab)

Recruiting
  • Sarcoma,Soft Tissue
  • anlotinib and toripalimab
  • Guangzhou, Guangdong, China
    Xing Zhang
Nov 15, 2021

Pathologically Confirmed Cancer Refractory to Conventional Therapy, Refractory Cancer, Metastatic Cancer Trial in Santa Monica

Not yet recruiting
  • Pathologically Confirmed Cancer Refractory to Conventional Therapy
  • +7 more
  • SNK02
  • Santa Monica, California
    Sarcoma Oncology Center
Aug 10, 2023

Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive

Recruiting
  • Malignant Abdominal Neoplasm
  • +26 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023